Home › BioMultiDeTeC
New multi-analytical biosensor technology for the early detection of breast cancer through liquid biopsy.
about the project
BioMultiDeTeC is an R&D&I project developed within the framework of the Science and Innovation Missions Programme 2024, aimed at the development of new biosanitary technology for the early detection of breast cancer through liquid biopsy. The project investigates an innovative diagnostic solution based on a multi-analytical biosensor capable of simultaneously detecting different types of tumor biomarkers, with the objective of improving accuracy, sensitivity, and early anticipation of clinical diagnosis, thereby contributing to a more personalized, efficient, and minimally invasive medicine.
general objective
To develop a disruptive biosanitary technology that enables the early detection of breast cancer through liquid biopsy by integrating, within a single system, the simultaneous detection of circulating tumor cells, protein tumor biomarkers, and microRNAs, thereby improving the sensitivity and specificity of clinical diagnosis.
specific objectives
consortium members
This multidisciplinary consortium combines the expertise of Mecwins in developing high-precision technologies for biomarker detection with the specialization of Destina Genomica in nucleic acid testing and advanced diagnostic assays.
contribution to european priorities
